Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of Arthritis
Authors:
- Hollis E. KrugHKHollis E. Krug
- Pari McGarraughPMPari McGarraugh
- Maren L. MahowaldMMMaren L. Mahowald
Open Access
- 1 October 2009
- journal article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 10 (7) , 1218-1228
Abstract
Objective. To evaluate the validity of newly developed pain behavior measures in two murine models of inflammatory arthritis and to determine the abiKeywords
This publication has 27 references indexed in Scilit:
- Predictors of Response to Botulinum Toxin Type A (BoNTA) in Chronic Daily HeadacheHeadache: The Journal of Head and Face Pain, 2007
- Evidence based medicine on the use of botulinum toxin for headache disordersJournal of Neural Transmission, 2007
- Effects of Intra-articular Botulinum Toxin Type A in an Equine Model of Acute SynovitisAmerican Journal of Physical Medicine & Rehabilitation, 2007
- Who, when, and why total joint replacement surgery? The patient's perspectiveCurrent Opinion in Rheumatology, 2006
- Pathophysiology and treatment of pain in joint disease☆Advanced Drug Delivery Reviews, 2006
- Botulinum Toxin A Relieved Neuropathic Pain in a Case of Post-Herpetic NeuralgiaPain Medicine, 2006
- Projections of US prevalence of arthritis and associated activity limitationsArthritis & Rheumatism, 2005
- Charlson's Index was a poor predictor of quality of life outcomes in a study of patients following joint replacement surgeryJournal of Clinical Epidemiology, 2005
- Quantitative assessment of botulinum toxin treatment in 43 patients with head tremorMovement Disorders, 1997
- Progressive ankylosis in miceArthritis & Rheumatism, 1988